Abstract
Penicillin allergy is reported by ∼10% of patients, but only 2-15% test positive on penicillin skin testing (PST). In inpatients, penicillin allergy is associated with worse clinical outcomes, increased costs, and antibiotic resistance. PST services have proven safe and effective in immunocompromised oncology patients, but uptake has been limited.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
